Pluri (PLUR) Share-based Compensation Growth (3y) (2013 - 2025)

Pluri (PLUR) Share-based Compensation Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 4.80%
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 10.78%
9 Abivax 95.45 Bn 95.45 Bn - -
10 Pluri 21.85 Mn 22.34 Mn 86,000.00 149.77%

Historic Data

Download Data
DateValue
Dec 31, 2025 149.77%
Sep 30, 2025 228.74%
Jun 30, 2025 -54.18%
Mar 31, 2025 80.99%
Dec 31, 2024 54.81%
Sep 30, 2024 -44.06%
Jun 30, 2024 -45.17%
Mar 31, 2024 -71.58%
Dec 31, 2023 121.24%
Sep 30, 2023 -6.90%
Jun 30, 2023 22.72%
Mar 31, 2023 42.42%
Dec 31, 2022 -34.08%
Sep 30, 2022 -64.70%
Jun 30, 2022 93.81%
Mar 31, 2022 -25.24%
Dec 31, 2021 -51.98%
Sep 30, 2021 33.93%
Jun 30, 2021 29.45%
Mar 31, 2021 64.86%